| Title : Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease - Syal_2020_Theranostics_10_6337 |
| Author(s) : Syal C , Kosaraju J , Hamilton L , Aumont A , Chu A , Sarma SN , Thomas J , Seegobin M , Dilworth FJ , He L , Wondisford FE , Zimmermann R , Parent M , Fernandes K , Wang J |
| Ref : Theranostics , 10 :6337 , 2020 |
| Abstract : Syal_2020_Theranostics_10_6337 |
| ESTHER : Syal_2020_Theranostics_10_6337 |
| PubMedSearch : Syal_2020_Theranostics_10_6337 |
| PubMedID: 32483456 |
Syal C, Kosaraju J, Hamilton L, Aumont A, Chu A, Sarma SN, Thomas J, Seegobin M, Dilworth FJ, He L, Wondisford FE, Zimmermann R, Parent M, Fernandes K, Wang J (2020)
Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease
Theranostics
10 :6337
Syal C, Kosaraju J, Hamilton L, Aumont A, Chu A, Sarma SN, Thomas J, Seegobin M, Dilworth FJ, He L, Wondisford FE, Zimmermann R, Parent M, Fernandes K, Wang J (2020)
Theranostics
10 :6337